The Biologics Market was valued at USD 433.77 billion in 2023 and is on track for a dramatic rise, with projections indicating it will reach USD 977.36 billion by 2032. This impressive growth is driven by a confluence of factors including rising investments in research and development, technological advancements in biologic therapies, and an increasing prevalence of...